Search
Septerna Inc
SEPNAdd to Watchlist
36.170USD
+0.370+1.03%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.61BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Septerna Inc is 8.44, ranking 122 out of 389 in the Biotechnology & Medical Research industry. The average price target is 29.00, with a high of 34.00 and a low of 25.00.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
46.750
Target Price
+29.25%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Septerna Inc
SEPN
10
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Septerna Inc's expected revenue for the next quarter?
Septerna Inc's expected revenue is 16.00M.
What is Septerna Inc's price target?
Analysts forecast that Septerna Inc's price target is USD 29.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 25.00.
How have Septerna IncSEPN's recent earnings per share performed?
The market expectation was USD -0.19, while Septerna IncSEPN's earnings per share (EPS) for the previous quarter was USD -0.24. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for Septerna Inc?
Based on the ratings of Septerna Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
